ARCHIVES

Ax Falls; Recision Asked Of $17 Million For NCI This Year, $42.7 Million Cut In FY 1981 Budget

This article is from The Cancer Letter archive.

Vol. 06 No. 14 | April 4, 1980

Download PDF Visit The Full Archive

Related Articles

NCI-Approved Clinical Trials

December 29, 2006

ODAC Votes For Accelerated Approval For Adcetris For Two Lymphoma Indications

July 22, 2011

In Brief: ‘WSJ” Articles Call Attention To Problems With Cancer Program Knipmeyer to Leave NCI

May 19, 1989

Drug Development: Tivozanib Trial Discontinued Due to Insufficient Enrollment

February 7, 2014

Reexamine Mandates, Samuels Suggests

February 17, 1984

GAO Report Finds Hydrazine Sulfate Trials Were Accurate

September 29, 1995